Cough Remedies Market (By Type: Expectorants, Bronchodilators, Antibiotics; By Dosage Form; By Age; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

The global cough remedies market size was estimated at around USD 9.94 billion in 2023 and it is projected to hit around USD 17.06 billion by 2033, growing at a CAGR of 5.55% from 2024 to 2033. The cough remedies market is driven by an increasing prevalence of respiratory ailments, growing health consciousness, continuous product innovation, and expansion of online retail channels.

Cough Remedies Market Size 2024 to 2033

Key Pointers

  • North America dominated the market with the largest market share in 2023.
  • Asia-Pacific region is projected to experience the highest CAGR from 2024 to 2033.
  • By Type, the expectorants segment held the largest revenue share in 2023.
  • By Dosage Form, the oral syrup segment dominated the market in 2023.
  • By Age, the adult segment generated the maximum market share in 2023.
  • By Distribution Channel, the retail pharmacy segment led the market in 2023.

Cough Remedies Market Overview

The global cough remedies market is witnessing significant growth driven by various factors such as increasing prevalence of respiratory ailments, rising pollution levels, and growing awareness about self-care and over-the-counter (OTC) medications. Cough remedies encompass a wide range of products, including cough syrups, lozenges, tablets, and herbal remedies, catering to different types and severities of cough.

Cough Remedies Market Growth

The growth of the cough remedies market is propelled by several key factors. Firstly, there's a rising prevalence of respiratory ailments worldwide, including conditions like asthma and bronchitis, which necessitates the need for effective cough remedies. Additionally, escalating pollution levels in urban areas contribute to respiratory irritations, driving the demand for cough relief products. Moreover, there's a notable increase in health consciousness among consumers, leading to a proactive approach towards managing minor ailments such as cough through over-the-counter remedies. Furthermore, continual product innovation by manufacturers, introducing new formulations and delivery methods, plays a pivotal role in expanding the market. Lastly, the proliferation of online retail channels provides consumers with convenient access to a wide array of cough remedies, further stimulating market growth. These factors collectively contribute to the robust expansion of the cough remedies market globally.

Cough Remedies Market Trends:

  • Growing Preference for Natural and Herbal Remedies: There's a notable shift towards natural and herbal cough remedies, driven by increasing consumer awareness about the potential side effects of synthetic medications and a preference for holistic healthcare approaches.
  • Rising Demand for Multi-Symptom Relief: Consumers are seeking cough remedies that provide relief not only for cough symptoms but also for accompanying symptoms such as sore throat, congestion, and runny nose. This trend has led to the development of multi-symptom cough relief formulations by manufacturers.
  • Emphasis on Fast-Acting Formulations: With busy lifestyles and a desire for quick relief, there's a growing demand for fast-acting cough remedies. Manufacturers are responding by introducing rapid-release formulations that provide immediate relief from cough symptoms.
  • Expansion of Pediatric Cough Remedies: There's an increasing focus on developing cough remedies specifically formulated for children, considering the unique needs and sensitivities of pediatric patients. This trend is driven by the growing incidence of cough and cold among children and the need for safe and effective treatments.
  • Adoption of Digital Health Solutions: The integration of digital health technologies, such as telemedicine platforms and mobile health apps, is influencing the cough remedies market. Consumers are seeking online consultations with healthcare professionals and accessing information about cough remedies through digital channels.
  • Personalized and Targeted Solutions: There's a growing interest in personalized healthcare solutions, including personalized cough remedies tailored to individual preferences and health conditions. This trend is driven by advancements in healthcare technology and a desire for more effective and personalized treatments.

Type Insights

The cough remedies market is categorized into various types, including expectorants, antihistamines, bronchodilators, antibiotics, and others. In 2023, the expectorants segment emerged as the largest market segment. This dominance can be credited to the introduction of new expectorant products aimed at providing early relief. For instance, in November 2022, Genexa Inc. unveiled its inaugural cough and chest congestion remedy for adults. This product is distinguished by its artificial inactive ingredient-free formulation, designed to alleviate chest congestion and temporarily control and loosen mucus. Administered orally, it is available in the form of a liquid suspension.

Dosage Form Insights

The market is divided based on dosage form into oral syrup, tablets/pills, lozenges, and others. In 2023, the oral syrup segment dominated the market. This dominance is largely due to the extensive availability of oral syrup brands and their easy administration. Additionally, factors such as new product development, high efficacy, and swift drug delivery are contributing to the increased utilization of oral syrup products worldwide.

Age Insights

The cough remedies market is divided by age into pediatric and adult segments. In 2023, the adult segment emerged as the largest market segment. This is primarily because adults commonly experience acute and chronic coughs, often attributed to unhealthy lifestyles and increased exposure to tobacco.

Cough Remedies Market Share, By Age, 2023 (%)

Chronic cough, especially prevalent among older adults, significantly impacts quality of life, as evidenced by a 2020 study published by the European Respiratory Society indicating that approximately 10% of the adult population suffers from this condition. Consequently, the expanding adult population is expected to fuel the demand for cough remedies in the foreseeable future.

Distribution Channel Insights

The cough remedies market is segmented based on distribution channels into retail and online pharmacies. In 2023, the retail pharmacy segment dominated the market. In Germany, for instance, approximately 18,068 community pharmacies, as reported by the Federal Union of German Associations of Pharmacists (ABDA), play a crucial role in meeting medical needs. The growth of this segment is supported by the availability of both branded and generic cough remedy products in retail pharmacy chains like Walgreens and Walmart Stores, Inc. Moreover, collaborations between hospitals and these pharmacy chains also contribute to the overall market expansion.

Regional Insights

In 2023, North America emerged as the leader in market share. The region benefits from a sizable patient population and the presence of well-established manufacturers, factors expected to bolster market growth further. The rapid adoption of remedies in North America reflects growing concerns among a significant number of individuals regarding the health risks associated with persistent coughing.

Cough Remedies Market Share, By Region, 2023 (%)

Meanwhile, the Asia-Pacific region is projected to experience the fastest compound annual growth rate (CAGR) during the forecast period. This growth can be attributed to factors such as rapidly expanding healthcare expenditure, improvements in healthcare infrastructure, a rising geriatric population, and the increasing prevalence of respiratory diseases in the Asia-Pacific region.

Cough Remedies Market Key Companies

  • BAYER AG
  • GLAXOSMITHKLINE PLC
  • PROCTER & GAMBLE (P&G)
  • PFIZER, INC.
  • JOHNSON & JOHNSON
  • SUN PHARMACEUTICALS INDUSTRIES LIMITED
  • Novartis International AG
  • Reckitt Benckiser Group plc.
  • PRESTIGE BRANDS INC.
  • ASTRAZENECA PLC

Cough Remedies Market Segmentations:

By Type

  • Expectorants
  • Antihistamines
  • Bronchodilators
  • Antibiotics
  • Others

By Dosage Form

  • Oral Syrup
  • Tablets/Pills
  • Lozenges
  • Others

By Age

  • Pediatric
  • Adult

By Distribution Channel

  • Retail
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global cough remedies market size was reached at USD 9.94 billion in 2023 and it is projected to hit around USD 17.06 billion by 2033.

The global cough remedies market is growing at a compound annual growth rate (CAGR) of 5.55% from 2024 to 2033.

The North America region has accounted for the largest cough remedies market share in 2023.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cough Remedies Market 

5.1. COVID-19 Landscape: Cough Remedies Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cough Remedies Market, By Type

8.1. Cough Remedies Market, by Type, 2024-2033

8.1.1. Expectorants

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Antihistamines

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Bronchodilators

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Antibiotics

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Others

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Cough Remedies Market, By Dosage Form

9.1. Cough Remedies Market, by Dosage Form, 2024-2033

9.1.1. Oral Syrup

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Tablets/Pills

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Lozenges

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Others

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Cough Remedies Market, By Age 

10.1. Cough Remedies Market, by Age, 2024-2033

10.1.1. Pediatric

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Adult

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Cough Remedies Market, By Distribution Channel 

11.1. Cough Remedies Market, by Distribution Channel, 2024-2033

11.1.1. Retail

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Online Pharmacies

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Cough Remedies Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.1.3. Market Revenue and Forecast, by Age (2021-2033)

12.1.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Age (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Age (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.2.3. Market Revenue and Forecast, by Age (2021-2033)

12.2.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Age (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Age (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Age (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Age (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.3.3. Market Revenue and Forecast, by Age (2021-2033)

12.3.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Age (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Age (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Age (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Age (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.4.3. Market Revenue and Forecast, by Age (2021-2033)

12.4.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Age (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Age (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Age (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Age (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.5.3. Market Revenue and Forecast, by Age (2021-2033)

12.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Age (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Dosage Form (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Age (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Distribution Channel (2021-2033)

Chapter 13. Company Profiles

13.1. BAYER AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. GLAXOSMITHKLINE PLC

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. PROCTER & GAMBLE (P&G)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. PFIZER, INC.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. JOHNSON & JOHNSON

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. SUN PHARMACEUTICALS INDUSTRIES LIMITED

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Novartis International AG

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Reckitt Benckiser Group plc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. PRESTIGE BRANDS INC.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. ASTRAZENECA PLC

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask to Expert